Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
(Image credit: Eva Marie Uzctegui/Bloomberg via Getty Images)
Subscribe to:
Post Comments
(
Atom
)
Post a Comment